Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
144 participants
INTERVENTIONAL
2018-10-22
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Amoxicillin Clavulanate in Treatment of Acute Otitis Media
NCT00299455
Effect of Antimicrobial Treatment of Acute Otitis Media on the Intestinal Microbiome in Children
NCT02935374
Amoxicillin-clavulanate in Treating Acute Otitis Media Evaluated by Daily Tympanometry
NCT01244581
Efficacy Study of Pristinamycin Versus Amoxicillin to Treat Tonsillitis Induced by Streptococcus in Children
NCT00393744
Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric Patients
NCT00799838
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treatment group 1
Reyanning mixture+amoxil capsule simulator
Reyanning mixture
Reyanning mixture , 20ml by mouth , 3 times per day for 7 days
amoxil capsule simulator
amoxil capsule simulator , 0.5g by mouth , 3 times per day for 7 days
treatment group 2
Reyanning mixture +amoxil capsule
Reyanning mixture
Reyanning mixture , 20ml by mouth , 3 times per day for 7 days
amoxil capsule
amoxil capsule , 0.5g by mouth , 3 times per day for 7 days
control group
Reyanning mixture simulator +amoxil capsule
amoxil capsule
amoxil capsule , 0.5g by mouth , 3 times per day for 7 days
Reyanning mixture simulator
Reyanning mixture simulator , 20ml by mouth , 3 times per day for 7 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reyanning mixture
Reyanning mixture , 20ml by mouth , 3 times per day for 7 days
amoxil capsule
amoxil capsule , 0.5g by mouth , 3 times per day for 7 days
Reyanning mixture simulator
Reyanning mixture simulator , 20ml by mouth , 3 times per day for 7 days
amoxil capsule simulator
amoxil capsule simulator , 0.5g by mouth , 3 times per day for 7 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Meet the traditional Chinese medicine symptom diagnostic criteria of external wind-heat type and excessive heat in the lung and stomach type;
3. 18 years≤age≤65 years;
4. course of disease within 72 hours;
5. sign informed consent.
Exclusion Criteria
2. complicated with acute tracheobronchitis,pneumonia,rheumatic fever, acute glomerulonephritis or rheumatic heart disease.
3. complicated with severe angiocardiopathy, cerebrovascular disease, hemopoietic system disease or psychopath.
4. liver or kidney function is abnormal(ALT\>1.5 times upper limit of normal; Cr\>upper limit of normal); diabetic.
5. WBC\<10×109/L and neutrophilic granulocyte percentage\<75%;or WBC ≥20×109/L;
6. gestational, lactating women or who planning to get pregnant within half a year.
7. already accept similar traditional Chinese medicine or antibiotic within 48 hours before registered.
8. joining other clinical trials or allergic to any drug in this trials.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
OTHER
Beijing Chao Yang Hospital
OTHER
Wangjing Hospital, China Academy of Chinese Medical Sciences
OTHER
Beijing First Hospital of integrated Chinese and Western Medicine
OTHER
China Academy of Chinese Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanming Xie
Deputy director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yanming Xie, BA
Role: PRINCIPAL_INVESTIGATOR
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Reyanning mixture
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.